Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OvaZoa F
- Development stage
- Unknown
- Lead developer
- MMC Healthcare
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Oral
01
Overview
OvaZoa F is a multi-ingredient nutritional supplement developed by MMC Healthcare Ltd (MMC Pharmaceuticals) specifically for female reproductive health and fertility support. Administered as oral softgel capsules, it is designed to protect oocytes (eggs) from oxidative damage and improve egg quality through its antioxidant properties. The formulation contains a synergistic blend of active ingredients including ubiquinol acetate (Coenzyme Q10), docosahexaenoic acid (DHA), L-arginine, L-methylfolate calcium, superoxide dismutase, vitamin D3 (cholecalciferol), selenomethionine, melatonin, and lycopene, along with minerals such as magnesium and zinc. These components work to enhance ovarian circulation, support mitochondrial energy production within oocytes, and promote healthy cell development. OvaZoa F is often utilized as an adjunct therapy for women seeking to improve fertility wellness or those undergoing in vitro fertilization (IVF) procedures.
- Brand names
- OvaZoa F
- Other names
- OvaZoa F Softgels
02
Targets
NOS1 (nNOS)Misfolded SOD1MTNR1A (MT1)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on OvaZoa F.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OvaZoa F.